Indications and uses
Temporary relief of pain associated with: Joint and Muscle Inflammation Nerve damage Fitness and Sports Injuries
Temporary relief of pain associated with: Joint and Muscle Inflammation Nerve damage Fitness and Sports Injuries
Apply generously to problem areas and rub the cream in completely, 2-3 times per day.
Tube contains tamper-evident seal under cap. Store between 15-30°C (60-86°F)
Drug Facts
| Active Ingredients: | PURPOSE |
|---|---|
| "HPUS" is an abbreviation for Homeopathic Pharmacopoeia of the United States | |
| Alpha-lipoic ac 4x HPUS (alpha-lipoic acid) | Antioxidant |
| Curcuma longa 4x (Turmeric extract) | Anti-inflammatory |
| Ocimum sanc 4x HPUS (Holy basil extract) | Anti-inflammatory |
| Olibanum 4x HPUS (Boswellia extract) | Anti-inflammatory |
| Rosmarinus 4x HPUS (Rosemary extract) | Analgesic |
| Salix Alba 4x HPUS (White willow extract) | Anti-inflammatory |
| Zingiber 4x HPUS (Ginger extract) | Anti-inflammatory |
Temporary relief of pain associated with:
For external use only.
Apply generously to problem areas and rub the cream in completely, 2-3 times per day.
Tube contains tamper-evident seal under cap. Store between 15-30°C (60-86°F)
Caprylyl Glycol, Cetylalcohol, Coco Caprylate/Caprate, Dimethicone, DMDM Hydantoin, Ethylhexylglycerin, Glycerin, Glyceryl Stearate, Hexylene Glycol, Octyl Methoxycinnamate, PEG-100 Stearate, Petrolatum, Phenoxyethanol, Stearic Acid, Stearyl Stearate, Tocopheryl Acetate (Vitamin-E), Water
877-NOXICARE
Manufactured in USA for Truceuticals® Inc.
5530 Wisconsin Avenue, Suite 1550
Chevy Chase, MD 20815
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51230-391-01 | 2019-11-27 | C162847 | 48780-1 | 9855d018-df73-cd31-e053-dbdaa90ab51a | NOXICARE™ |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51230-391-01 | NOXICARE | 1 in 1 CARTON | CREAM | 1 | 2 | |
| 51230-391-01 | NOXICARE | 100 mL in 1 TUBE | CREAM | 100 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51230-391 | NOXICARE (.ALPHA.-LIPOIC ACID, TURMERIC, OCIMUM TENUIFLORUM TOP, INDIAN FRANKINCENSE, ROSEMARY, SALIX ALBA BARK, AND GINGER) CREAM [TRUCEUTICALS, LLC] | 2 | Legacy NDC, 2 package rows | 20130208_f6bd40be-6f2c-48b0-8a5c-fc0dc7285d29.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .Alpha.-Lipoic Acid | ACTIVE INGREDIENT | 73Y7P0K73Y | 2 | |
| Ginger | ACTIVE INGREDIENT | C5529G5JPQ | 2 | |
| Indian Frankincense | ACTIVE INGREDIENT | 4PW41QCO2M | 2 | |
| Ocimum Tenuiflorum Top | ACTIVE INGREDIENT | 34T63W8ULS | 2 | |
| Rosemary | ACTIVE INGREDIENT | IJ67X351P9 | 2 | |
| Salix Alba Bark | ACTIVE INGREDIENT | 205MXS71H7 | 2 | |
| Turmeric | ACTIVE INGREDIENT | 856YO1Z64F | 2 | |
| .Alpha.-Lipoic Acid | ACTIVE MOIETY | 73Y7P0K73Y | 2 | |
| Ginger | ACTIVE MOIETY | C5529G5JPQ | 2 | |
| Indian Frankincense | ACTIVE MOIETY | 4PW41QCO2M | 2 | |
| Ocimum Tenuiflorum Top | ACTIVE MOIETY | 34T63W8ULS | 2 | |
| Rosemary | ACTIVE MOIETY | IJ67X351P9 | 2 | |
| Salix Alba Bark | ACTIVE MOIETY | 205MXS71H7 | 2 | |
| Turmeric | ACTIVE MOIETY | 856YO1Z64F | 2 | |
| .Alpha.-Tocopherol | INACTIVE INGREDIENT | H4N855PNZ1 | 2 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 2 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| Coco-Caprylate/Caprate | INACTIVE INGREDIENT | 8D9H4QU99H | 2 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| DMDM Hydantoin | INACTIVE INGREDIENT | BYR0546TOW | 2 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| Glyceryl Monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 2 | |
| Hexylene Glycol | INACTIVE INGREDIENT | KEH0A3F75J | 2 | |
| Octinoxate | INACTIVE INGREDIENT | 4Y5P7MUD51 | 2 | |
| PEG-100 Stearate | INACTIVE INGREDIENT | YD01N1999R | 2 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 | |
| Stearyl Stearate | INACTIVE INGREDIENT | 5WX2EGD0DK | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51230-391 | 51230-391-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| DMDM Hydantoin | DMDM HYDANTOIN | BYR0546TOW | LOTION / TOPICAL | 3 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 59 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / TOPICAL | 836 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, EXTENDED RELEASE / ORAL | 132 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / VAGINAL | 200 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / SUBLINGUAL | 1.23 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Hexylene Glycol | HEXYLENE GLYCOL | KEH0A3F75J | OINTMENT / TOPICAL | 12 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUPPOSITORY / RECTAL | 35 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| Hexylene Glycol | HEXYLENE GLYCOL | KEH0A3F75J | SOLUTION / TOPICAL | 0.3 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| PEG-100 Stearate | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 52adf0e7-14dd-4833-a166-1a4afff4ff11 | f6bd40be-6f2c-48b0-8a5c-fc0dc7285d29 | 2012-12-20 | Warnings | 52adf0e7-14dd-4833-a166-1a4afff4ff11 f6bd40be-6f2c-48b0-8a5c-fc0dc7285d29 |
Adverse event summaries are temporarily unavailable. Other product information remains available.